Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The NHS recommends that anyone starting medical treatment for weight loss should have regular monitoring to track progress, manage side effects, and make sure the treatment is right for them
Clinical trials reveal that patients, on average, achieve 15-20% weight reduction when combining semaglutide with lifestyle modifications
Seniors who are already getting GLP-1 medications paid for by their Part D insurer because those drugs were prescribed for type 2 diabetes or another condition Medicare already covers fall outside the Bridge program's eligibility boundaries
Use in Pregnancy Zepbound is not recommended during pregnancy: Weight loss is not advised during pregnancy Potential risks to fetal development are not fully understood Alternative approaches should be considered in pregnant individuals
